This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Keyword Search

Keyword Search Criteria: vaccine returned 16 record(s)
Monday, 08/02/2010
Transfer of Methods Supporting Biologics and Vaccines
Rong Liu, Merck & Co., Inc.; Timothy Schofield, GlaxoSmithKline; Jason Liao, Merck Research Laboratories


Tuesday, 08/03/2010
Some Issues in Risk Analysis of Drug Products
Tony Lachenbruch, Oregon State University


Immunological Correlates of Protection: Some Recent Methodological Developments and Future Challenges
Andrew J. Dunning, sanofi pasteur
2:05 PM

Evaluating Correlates of Protection in Vaccine Studies
Ivan S.F. Chan, Merck Research Laboratories
2:25 PM

Principal Stratification Methods for Evaluating Immunological Surrogate Endpoints in a Vaccine Efficacy Trial
Peter Gilbert, Fred Hutchinson Cancer Research Center
2:45 PM

Wednesday, 08/04/2010
A Bayesian Generalized Linear Mixed Model for HIV-1 Vaccine Immune Response with Missing Data
Sydeaka Patrice Watson, Baylor University; John Seaman, Baylor University; James Stamey, Baylor University; Bette Korber, Los Alamos National Laboratory; Mark Muldoon, University of Manchester


Bias Correction for Rare Events in Self-Controlled Case Series Design of Vaccine Safety
Chan Zeng, Kaiser Permanente Colorado; Jason M. Glanz, Kaiser Permanente Colorado; Sophia R. Newcomer, Kaiser Permanente Colorado; Stanley Xu, Kaiser Permanente Colorado


Using Proportion of Similar Response (PSR) to Evaluate Correlates of Protection for Vaccine Efficacy
Katherine Giacoletti, Merck & Co., Inc.; Joseph Heyse, Merck Research Laboratories
10:50 AM

Considerations in Vaccine Lot Consistency Trials
Xiao Sun, Merck Research Laboratories; Joshua Chen, Merck Research Laboratories
11:05 AM

Statistical Inference Following an Adaptive Design for Case-Driven Efficacy Study
Xiaoming Li, Merck Research Laboratories; Ivan S.F. Chan, Merck Research Laboratories; Keaven M. Anderson, Merck Research Laboratories
11:20 AM

Comparing Proportions of Extremely Rare Events of Uncertain Status with Applications to Vaccine Safety Studies
Hongyuan Cao, The University of North Carolina at Chapel Hill; Lisa M. LaVange, The University of North Carolina at Chapel Hill; Joseph Heyse, Merck Research Laboratories; Michael Kosorok, The University of North Carolina at Chapel Hill
11:35 AM

Statistical Modeling of the Duration of Protection of Postvaccination Antibody
Jason Martin, Merck & Co., Inc.; Stephanie Klopfer, Merck & Co., Inc.
11:50 AM

Calling Hits in a High-Throughput Screening Assay
Minya Pu, University of California, San Diego; Karen Messer, University of California, San Diego
12:05 PM

Estimation of Odds Ratio with Rare Event Case: A Simulation Study Based on Hospitalized Flu Vaccine Study
Qingxia Chen, Vanderbilt University; Yuwei Zhu, Vanderbilt University; Helen K.B. Talbot, Vanderbilt University; Marie R. Griffin, Vanderbilt University; Kathryn M. Edwards, Vanderbilt University
3:20 PM

Thursday, 08/05/2010
Establishing Best Predictors for Completion of the HPV4 Vaccine Sequence by Female Patients at Clinics of Johns Hopkins Medical Institutions
Christopher E. Barat, Stevenson University; Courtney Wright, Stevenson University; Betty Chou, The Johns Hopkins University
11:05 AM

Using a Nonlinear Mixed Effects Model to Estimate Anthrax Antibody Longevity and Decay
Lydia S.D. Foster, Atlanta Research and Education Foundation; Charles E. Rose, Jr., CDC; Conrad Quinn, CDC
11:50 AM




2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.